Health ❯Healthcare ❯Clinical Trials

Randomized Controlled Trials

Efficacy Studies Patient Outcomes Hypertonic Saline Study Sulthiame in OSA Pharmacological Therapy EPIC-HR and EPIC-SR Trials Pain Relief Studies Medication Effects Double-Blind Studies Neurodevelopmental Research Telehealth Studies AML17 and AML19 Trials Vaping Studies BRAID Trial Pain and Emotion Therapy Weight Loss Efficacy Drug Comparison Daratumumab Therapy Phase 3 Trials PREDMETH Trial Exercise Intervention Medication Effectiveness Intervention Studies Exercise and Cancer Intimate Partner Violence Research Transcranial Direct Current Stimulation (tDCS) DETECT Hep C Trial Sepsis Treatment PRODROME Study

Two-Dose Ondansetron Regimen Recommended for Children After ED Gastroenteritis

The national trial’s findings drove July 18 recommendations enabling emergency departments to supply two at-home ondansetron doses.

Intermittent Energy Restriction Shows Greatest Benefits in Diabetes Weight-Loss Trial

Guidelines Shift to Universal Hepatitis C Screening in Emergency Departments After Trial Shows 34% Boost in Case Detection

Preoperative Exercise Strengthens Tumor Immunity and Reveals Early Remission Signals in OPTIMUS Trial

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

UK Study Advocates New Breast Cancer Screening for Women with Dense Tissue

Study Highlights Patient-Reported Physical Function as Key Predictor of Daratumumab Success in Multiple Myeloma

Online Therapy Targets Emotions to Reduce Chronic Pain, Study Shows

New Bone Marrow Test Doubles Survival for Some AML Patients, Study Confirms

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Varenicline Triples Youth Vaping Quit Rates in Groundbreaking Trial

Study Confirms ADHD Medications Offer Significant Benefits with Manageable Cardiovascular Risks

FDA Approves First Treatment for Niemann-Pick Disease Type C

Epilepsy Drug Sulthiame Shows Promise in Treating Sleep Apnea

Study Finds Saltwater Nose Drops Shorten Children's Colds by Two Days

New Migraine Drug Ubrogepant Shows Promise in Early Symptom Treatment